September/October 2023

• NPAC’s ED presented at the European Pain Federation’s 2023 Congress on a global initiative to establish core research domains for pain. She spoke about involving people living with pain, whose votes were weighted equally to those of researchers and clinicians. 

• NPAC was selected to present at the Drug Enforcement Administration’s listening Session on Telemedicine Prescribing. NPAC’s President provided its testimony.

• NPAC successfully advocated with The Board of Pharmacy Specialties (BPS) to create a new specialty in pain management pharmacy. 

• NPAC’s Executive Director, Kate Nicholson, and Science and Policy Advisors, Baker and Mallampalli, participated in the fall meeting of the Interagency Pain Research Coordinating Committee.

• NPAC’s Executive Director joined the governing board of NIH PURPOSE, a new initiative to build the pain workforce and support collaboration among researchers.

• NPAC’s Executive Director spoke in Washington, D.C., to the 2023 Mayday Pain and Society Fellows on strategies for advocacy and policy change.

• NPAC’s Executive Director met with policymakers on Capitol Hill regarding recent federal legislation related to pain.